These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12172978)

  • 1. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial.
    Vail DM; Kurzman ID; Glawe PC; O'Brien MG; Chun R; Garrett LD; Obradovich JE; Fred RM; Khanna C; Colbern GT; Working PK
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):131-6. PubMed ID: 12172978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).
    Bacon NJ; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
    J Am Vet Med Assoc; 2008 May; 232(10):1504-10. PubMed ID: 18479240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.
    Phillips B; Powers BE; Dernell WS; Straw RC; Khanna C; Hogge GS; Vail DM
    J Am Anim Hosp Assoc; 2009; 45(1):33-8. PubMed ID: 19122062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
    McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
    J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993).
    Bergman PJ; MacEwen EG; Kurzman ID; Henry CJ; Hammer AS; Knapp DW; Hale A; Kruth SA; Klein MK; Klausner J; Norris AM; McCaw D; Straw RC; Withrow SJ
    J Vet Intern Med; 1996; 10(2):76-81. PubMed ID: 8683484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma.
    Kozicki AR; Robat C; Chun R; Kurzman ID
    Vet Comp Oncol; 2015 Sep; 13(3):229-36. PubMed ID: 23663234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma.
    Selmic LE; Burton JH; Thamm DH; Withrow SJ; Lana SE
    J Vet Intern Med; 2014; 28(2):554-63. PubMed ID: 24512451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy.
    Heishima K; Meuten T; Yoshida K; Mori T; Thamm DH
    BMC Vet Res; 2019 Jan; 15(1):39. PubMed ID: 30683101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy.
    Matsuyama A; Schott CR; Wood GA; Richardson D; Woods JP; Mutsaers AJ
    J Am Vet Med Assoc; 2018 Jun; 252(11):1377-1383. PubMed ID: 29772973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.
    Skorupski KA; Uhl JM; Szivek A; Allstadt Frazier SD; Rebhun RB; Rodriguez CO
    Vet Comp Oncol; 2016 Mar; 14(1):81-7. PubMed ID: 24118677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin.
    Kurzman ID; MacEwen EG; Rosenthal RC; Fox LE; Keller ET; Helfand SC; Vail DM; Dubielzig RR; Madewell BR; Rodriguez CO
    Clin Cancer Res; 1995 Dec; 1(12):1595-601. PubMed ID: 9815961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs.
    Kent MS; Strom A; London CA; Seguin B
    J Vet Intern Med; 2004; 18(4):540-4. PubMed ID: 15320595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
    London CA; Gardner HL; Mathie T; Stingle N; Portela R; Pennell ML; Clifford CA; Rosenberg MP; Vail DM; Williams LE; Cronin KL; Wilson-Robles H; Borgatti A; Henry CJ; Bailey DB; Locke J; Northrup NC; Crawford-Jakubiak M; Gill VL; Klein MK; Ruslander DM; Thamm DH; Phillips B; Post G
    PLoS One; 2015; 10(4):e0124889. PubMed ID: 25923466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006-2010).
    Simcock JO; Withers SS; Prpich CY; Kuntz CA; Rutland BE
    J Am Vet Med Assoc; 2012 Sep; 241(5):608-14. PubMed ID: 22916858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of carboplatin and toceranib phosphate on serum vascular endothelial growth factor (VEGF) and metalloproteinase-9 (MMP-9) levels and survival in canine osteosarcoma.
    Gieger TL; Nettifee-Osborne J; Hallman B; Johannes C; Clarke D; Nolan MW; Williams LE
    Can J Vet Res; 2017 Jul; 81(3):199-205. PubMed ID: 28725110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006).
    Saam DE; Liptak JM; Stalker MJ; Chun R
    J Am Vet Med Assoc; 2011 Jan; 238(2):195-206. PubMed ID: 21235373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs.
    LeBlanc AK; Mazcko CN; Cherukuri A; Berger EP; Kisseberth WC; Brown ME; Lana SE; Weishaar K; Flesner BK; Bryan JN; Vail DM; Burton JH; Willcox JL; Mutsaers AJ; Woods JP; Northrup NC; Saba C; Curran KM; Leeper H; Wilson-Robles H; Wustefeld-Janssens BG; Lindley S; Smith AN; Dervisis N; Klahn S; Higginbotham ML; Wouda RM; Krick E; Mahoney JA; London CA; Barber LG; Balkman CE; McCleary-Wheeler AL; Suter SE; Martin O; Borgatti A; Burgess K; Childress MO; Fidel JL; Allstadt SD; Gustafson DL; Selmic LE; Khanna C; Fan TM
    Clin Cancer Res; 2021 Jun; 27(11):3005-3016. PubMed ID: 33753454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine osteosarcoma: amputation and chemoimmunotherapy.
    MacEwen EG; Kurzman ID
    Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):123-33. PubMed ID: 8825571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine osteosarcoma: amputation and chemotherapy.
    Berg J
    Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):111-21. PubMed ID: 8825570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990).
    Thompson JP; Fugent MJ
    J Am Vet Med Assoc; 1992 Feb; 200(4):531-3. PubMed ID: 1559895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.